Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	B:C2609162
Femoral	O
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	O
femoral	O
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	B:C0015802
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	O
femoral	O
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	O
Fractures	I:C0015802
Vancouver	B:C0008902
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	O
femoral	O
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	O
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	B:C0543467
treatment	I:C0543467
of	O
periprosthetic	O
femoral	O
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	O
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	B:C2609162
femoral	O
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	O
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	O
femoral	B:C0015802
fractures	I:C0015802
has	O
a	O
high	O
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

Midterm	O
Results	O
of	O
Consecutive	O
Periprosthetic	O
Femoral	O
Fractures	I:C0015802
Vancouver	O
Type	I:C0008902
A	I:C0008902
and	I:C0008902
B	I:C0008902
Surgical	O
treatment	I:C0543467
of	O
periprosthetic	O
femoral	O
fractures	I:C0015802
has	O
a	O
high	B:C0009566
complication	I:C0009566
and	O
mortality	O
rate	O
of	O
more	O
than	O
10	O
%	O
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
is	O
to	O
report	O
the	O
outcome	O
of	O
a	O
consecutive	O
single	O
center	O
patient	O
group	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
report	B:C0684224
the	O
outcome	O
of	O
a	O
consecutive	O
single	O
center	O
patient	O
group	O
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	B:C2609162
femoral	O
fracture	I:C0015802
Vancouver	O
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	O
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	O
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	O
femoral	B:C0015802
fracture	I:C0015802
Vancouver	O
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	O
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	O
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	O
femoral	O
fracture	I:C0015802
Vancouver	B:C0008902
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	O
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	O
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	O
femoral	O
fracture	I:C0015802
Vancouver	O
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	B:C0008902
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	O
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	O
femoral	O
fracture	I:C0015802
Vancouver	O
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	O
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	B:C1522577
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Thirty	O
-	O
four	O
consecutive	O
patients	O
(	O
mean	O
age	O
81.2+/-	O
8.5	O
years	O
,	O
14	O
male	O
,	O
20	O
female	O
)	O
with	O
a	O
periprosthetic	O
femoral	O
fracture	I:C0015802
Vancouver	O
type	I:C0008902
A	I:C0008902
(	O
n=5	O
)	O
or	O
type	O
B	I:C0008902
(	O
n=29	O
)	O
were	O
followed	O
-	I:C1522577
up	I:C1522577
after	O
43.2	O
months	O
,	O
none	O
of	O
the	O
patients	O
were	O
lost	O
to	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

Nineteen	O
of	O
the	O
patients	O
were	O
treated	O
through	O
change	O
of	O
the	O
stem	B:C0025080
and	O
cerclage	O
fixation	O
,	O
five	O
by	O
plates	O
and	O
ten	O
by	O
cerclage	O
cables	I:C0025080
.	O

Nineteen	O
of	O
the	O
patients	O
were	O
treated	O
through	O
change	O
of	O
the	O
stem	O
and	O
cerclage	O
fixation	O
,	O
five	O
by	O
plates	B:C0005971
and	O
ten	O
by	O
cerclage	O
cables	I:C0025080
.	O

Nineteen	O
of	O
the	O
patients	O
were	O
treated	O
through	O
change	O
of	O
the	O
stem	O
and	O
cerclage	O
fixation	O
,	O
five	O
by	O
plates	O
and	O
ten	O
by	O
cerclage	B:C0025080
cables	I:C0025080
.	O

One	O
successfully	O
treated	O
infection	B:C3714514
was	O
observed	O
.	O

No	O
further	O
complications	B:C0009566
have	O
been	O
reported	O
peri-	O
or	O
postoperatively	O
,	O
therefore	O
resulting	O
in	O
2.9	O
%	O
overall	O
complication	O
rate	O
.	O

No	O
further	O
complications	O
have	O
been	O
reported	B:C0700287
peri-	O
or	O
postoperatively	O
,	O
therefore	O
resulting	O
in	O
2.9	O
%	O
overall	O
complication	O
rate	O
.	O

These	O
results	O
demonstrate	O
that	O
precisely	O
selected	O
revision	B:C0558347
surgery	O
protocol	O
following	O
periprosthetic	O
femoral	O
fractures	I:C0015802
within	O
elderly	O
multimorbid	O
patients	O
may	O
lead	O
to	O
beneficial	O
outcomes	O
at	O
a	O
low	O
risk	O
of	O
complications	O
.	O

These	O
results	O
demonstrate	O
that	O
precisely	O
selected	O
revision	O
surgery	O
protocol	O
following	O
periprosthetic	B:C2609162
femoral	O
fractures	I:C0015802
within	O
elderly	O
multimorbid	O
patients	O
may	O
lead	O
to	O
beneficial	O
outcomes	O
at	O
a	O
low	O
risk	O
of	O
complications	O
.	O

These	O
results	O
demonstrate	O
that	O
precisely	O
selected	O
revision	O
surgery	O
protocol	O
following	O
periprosthetic	O
femoral	B:C0015802
fractures	I:C0015802
within	O
elderly	O
multimorbid	O
patients	O
may	O
lead	O
to	O
beneficial	O
outcomes	O
at	O
a	O
low	O
risk	O
of	O
complications	O
.	O

These	O
results	O
demonstrate	O
that	O
precisely	O
selected	O
revision	O
surgery	O
protocol	O
following	O
periprosthetic	O
femoral	O
fractures	I:C0015802
within	O
elderly	B:C0001792
multimorbid	O
patients	O
may	O
lead	O
to	O
beneficial	O
outcomes	O
at	O
a	O
low	O
risk	O
of	O
complications	O
.	O

These	O
results	O
demonstrate	O
that	O
precisely	O
selected	O
revision	O
surgery	O
protocol	O
following	O
periprosthetic	O
femoral	O
fractures	I:C0015802
within	O
elderly	O
multimorbid	O
patients	O
may	O
lead	O
to	O
beneficial	O
outcomes	O
at	O
a	O
low	O
risk	O
of	O
complications	B:C0009566
.	O

